| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20K | — | -88.5% |
| Cost of Revenue | $0 | — | — |
| Gross Profit | $20K | — | -88.5% |
| R&D Expense | $475K | -29.2% | -71.8% |
| SG&A Expense | $997K | +10.4% | -19.6% |
| Operating Income | -$1.5M | +7.7% | +47.2% |
| Income Tax | $3K | +45.1% | — |
| Net Income | -$1.4M | +9.1% | +46.6% |
| EPS (Diluted) | -$0.06 | +14.3% | +60.0% |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.1M | +18.6% | -21.5% |
| Short-term Investments | $141K | -1.4% | +91.1% |
| Accounts Receivable | $42K | -52.3% | -87.3% |
| Current Assets | $5.8M | +7.6% | -25.3% |
| Total Assets | $6.5M | +7.2% | -25.2% |
| Current Liabilities | $215K |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.1M | -219.9% | — |
| Capital Expenditures | $41K | — | — |
| Investing Cash Flow | -$59K | -1057.2% | — |
| Financing Cash Flow | $6.5M | +87.6% | — |
| Free Cash Flow | -$3.2M | -224.0% | — |
| -88.2% |
| Total Liabilities | $277K | -81.9% | -85.5% |
| Stockholders' Equity | $6.6M | +34.4% | -7.6% |